CubaTuberculosis profile
Population  2014 11 million
Estimates of TB burden * 2014 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.029 (0.029–0.029) 0.25 (0.25–0.26)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.06 (0.05–0.08)
Prevalence  (includes HIV+TB) 1.5 (0.75–2.4) 13 (6.6–21)
Incidence  (includes HIV+TB) 1.1 (0.92–1.2) 9.4 (8.1–11)
Incidence (HIV+TB only) 0.11 (0.093–0.13) 0.97 (0.82–1.1)
         
Case detection, all forms (%) 68 (60–79)    
Estimates of MDR-TB burden * 2014   New   Retreatment
% of TB cases with MDR-TB 0.74 (0.09–2.7) 4.2 (0.51–14)
MDR-TB cases among notified pulmonary
TB cases
4 (1–16) 3 (0–9)
TB case notifications 2014 New ** Relapse
Pulmonary, bacteriologically confirmed 467   41
Pulmonary, clinically diagnosed 130   7
Extrapulmonary 80   4
       
Total new and relapse 729    
Previously treated, excluding relapses 13    
Total cases notified 742    
Among 729 new and relapse cases:
15 (2%) cases aged under 15 years; male:female ratio: 3.3
Reported cases of RR-/MDR-TB 2014 New Retreatment Total **
Cases tested for RR-/MDR-TB 310 (66%) 56 (86%) 366
Laboratory-confirmed RR-/MDR-TB cases     10
Patients started on MDR-TB treatment ***     10
TB/HIV 2014 Number (%)
TB patients with known HIV status 736 (99)
HIV-positive TB patients 87 (12)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 4 (5)
HIV-positive TB patients on antiretroviral therapy (ART) 72 (83)
HIV-positive people screened for TB 1 337  
HIV-positive people provided with IPT 1 300  
Treatment success rate and cohort size (%) Cohort
New and relapse cases registered in 2013 (84) 747
Previously treated cases, excluding relapse, registered in 2013 (28) 18
HIV-positive TB cases, all types, registered in 2013 (57) 58
RR-/MDR-TB cases started on second-line treatment in 2012 (67) 6
XDR-TB cases started on second-line treatment in 2012   2
Laboratories 2014  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2015  
National TB programme budget (US$ millions) 26
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
*** Includes patients diagnosed before 2014 and patients who were not laboratory-confirmed as having
RR-/MDR-TB
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2016-08-31 Data: www.who.int/tb/data